Methocarbamol: adjunct therapy for pain management in breast augmentation.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 19331993.
- Also identified by DOI 10.1067/maj.2002.126750.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Since 1994, the author has used methocarbamol as an adjunct for pain management in patients undergoing subpectoral breast implant surgery. According to his observations, methocarbamol results in a decrease in postoperative pain and use of intravenous narcotics, as well as significant improvement in postoperative functioning. (Aesthetic Surg J 2002;22:380-381.).